Pharmaceuticals

Quinine Market Anticipated to Record Steady Gains, Advancing to $3.76 Billion by 2030

February 18, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the quinine market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Quinine Market expected to reach by 2030?

The quinine market size has experienced strong growth in recent years. It is projected to expand from $2.45 billion in 2025 to $2.68 billion in 2026, at a compound annual growth rate (CAGR) of 9.2%. This growth observed in the historic period can be attributed to traditional reliance on cinchona bark extraction, limited availability of purified quinine, widespread use in malaria treatment, its inclusion in home remedies and tonic beverages, and the adoption of oral formulations.

The quinine market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $3.76 billion, exhibiting a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period stems from several factors, including improvements in quinine synthesis and purification technologies, an increase in the need for pharmaceutical-grade quinine, the broadening scope of malaria control initiatives, the proliferation of functional beverages that incorporate quinine, and greater financial commitment to antimalarial research and development. Key trends observed within this period encompass a growing preference for natural antimalarial agents, the expanding application of quinine in tonic drinks and functional beverages, the creation of refined pharmaceutical-grade quinine derivatives, heightened public understanding concerning malaria prevention and its remedies, and a strong emphasis on adhering to regulatory guidelines and upholding quality benchmarks for quinine-based goods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24676&type=smp

What Drivers Are Driving Adoption Within The Quinine Market?

The increasing incidence of malaria is projected to fuel the expansion of the quinine market in the coming years. Malaria, an infectious ailment, is caused by Plasmodium parasites and spreads to people via the bite of infected female Anopheles mosquitoes. The rise in malaria cases is linked to escalating global temperatures, which broaden the dwelling areas and reproductive cycles of malaria-transmitting mosquitoes. Quinine, a powerful antimalarial medication, combats malaria by disrupting the parasite’s capacity to process hemoglobin within red blood cells, thereby impeding its development and existence. For example, in April 2024, the UK Health Security Agency, a government body based in the UK, reported that confirmed malaria cases in England rose to 2,004 in 2023, an increase from 1,369 cases recorded in 2022. Consequently, the growing occurrence of malaria is propelling the development of the quinine market.

How Is The Quinine Market Organized Into Various Segments?

The quinine market covered in this report is segmented –

1) By Product: Quinine Sulphate, Quinine Hydrochloride, Quinine Gluconate, Quinine Bisulphate

2) By Administration: Oral Administration, Intramuscular Administration, Intravenous Administration, Other Administrations

3) By Application: Malaria Treatment, Nocturnal Leg Cramps

4) By Enduser: Hospitals, Clinics, Other Endusers

Who Are The Prominent Global Companies Shaping The Quinine Market Landscape?

Major companies operating in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., Sakhiya Pharma Chem

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/quinine-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Quinine Market?

North America was the largest region in the quinine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quinine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Quinine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24676&type=smp

Browse Through More Reports Similar to the Global Quinine Market 2026, By The Business Research Company

Malaria Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Malaria Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Chitosan Market Report 2026

https://www.thebusinessresearchcompany.com/report/chitosan-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795